MSD Innovation Factory: INNOREP Challenge - Creating Memorable Experiences for Healthcare Professionals

MSD Innovation FactoryNowadays, pharmaceutical launches are becoming harder and more competitive. In some cases, MSD products are neither the only nor the first player in the market. Besides, clinical data can be comparable with the products of other laboratories.

Healthcare professionals tend to prescribe the products that they are familiar with and knowledgeable about (what is known as 'top of mind'). Therefore, all pharmaceutical companies focus on face-to-face interaction done by representatives (reps) as an anchor for the exchange of product scientific information with the healthcare professionals.

It is hard for the healthcare professionals to remember the features and value of MSD products due to the limited time they spend with MSD reps, the overall number of reps the see per week (more than 10) together with the cognitive overload and fatigue of dealing with approximately 4 products per interaction.

On average, 87% of healthcare professionals contacts with pharmaceutical sales reps last less than two minutes, which is not enough for impactful product discussion.

Currently MSD sales reps are equipped with Tablets and Laptops for their daily job. However, based on experience, using them in the wrong way can distract the physician from the conversation.

The need
Help MSD reps to set themselves apart from the other reps while interacting with healthcare professionals. MSD is looking for innovative solutions or approaches to support the interaction with healthcare professionals in an ethical unique, engaging and memorable manner.

Expected outputs
Innovative, engaging and impactful solution or approach for having scientific discussions with healthcare professionals and key stakeholders, taking full advantage of the MSD product studies, clinical papers and scientific materials. The solution or approach should be cost-effective. Please refer to the rules for further information on permissible solutions

Deadline date: December 30th 2016, 23:59:59 UTC

For further information and to apply, please visit:
http://www.msdinnovationfactory.com

About MSD (EEMEA)
MSD (in the United States and Canada known as Merck & Co., Inc., Kenilworth, NJ USA) during its 125 years of successful health and medicines innovation achievements is eager to find new and better ways to provide breakthrough medicines and healthcare services to patients and healthcare professionals around the world converging to a new stage of co creation now with the Health Tech Eco System.

That is why the EEMEA (Eastern Europe, Middle East and Africa) MSD Organization is opening the doors for entrepreneurs and ideators to come up with articulable solutions for 3 of our most important needs across all countries within this geographical region. A total of 9 finalists (3 for each need/challenge) will not only have the opportunity to showcase their proposal and debate with MSD experts how to co create together but also will have the chance to earn 3.000€ if selected as the most articulate and innovative solution.

The EEMEA Innovation Factory has been launched in partnership with TICBioMed a Digital Health association specialized in providing business support.

Most Popular Now

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

Patients say "Yes..ish" to the…

As artificial intelligence (AI) continues to be integrated in healthcare, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

Brains vs. Bytes: Study Compares Diagnos…

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...